8-K: BEN Forms Skye Salud to Modernize Mexico Healthcare with AI

Brand Engagement Network, Inc. partners with KNOBLOCH Information Group and Skye Inteligencia LATAM to launch Skye Salud, a new venture aimed at deploying Mexico's first nationwide sovereign augmented-intelligence platform for healthcare.

Summary

• Brand Engagement Network, Inc. (BEN) has partnered with KNOBLOCH Information Group and Skye Inteligencia LATAM to form Skye Salud, a new Mexican S.A.P.I.
• Skye Salud will deploy Mexico's first nationwide sovereign augmented-intelligence platform to modernize clinical workflows, enhance patient safety, and expand access to high-quality care for over 130 million people.
• The platform is designed to be secure, Spanish-language native, and integrate seamlessly with existing systems, with initial pilot programs targeted for Q1 2026.
• BEN will receive 35% of applicable gross revenues generated by Skye Inteligencia LATAM's operations, including those related to Skye Salud, through existing licensing and shareholder agreements.
• KNOBLOCH Information Group and Skye Inteligencia LATAM each hold 50% ownership in Skye Salud, with Skye Inteligencia LATAM holding two of the three board seats.
• KNOBLOCH Information Group is Mexico's leading independent provider of pharmaceutical market intelligence, auditing 99% of the private pharmaceutical market and covering nearly 85% of the overall Mexican pharmaceutical market at the sell-out level.
• The Mexican EHR and EMR market is projected to grow from USD $2.4 billion in 2025 to USD $5.3 billion by 2031, at approximately 14% CAGR.

Sentiment

Score: 8

Explanation: The announcement is highly positive, detailing a significant strategic partnership in a high-growth market with clear revenue opportunities for BEN and strong leadership. The potential for impact on Mexican healthcare is substantial, and the market projections are favorable. The only minor detraction is the standard forward-looking statement disclaimer, which is typical for such announcements.

Positives

• The formation of Skye Salud addresses urgent challenges in Mexico's massive and high-growth healthcare market, serving over 130 million people.
• The partnership with KNOBLOCH Information Group provides unmatched access to comprehensive, real-time pharmaceutical data and strong relationships across public institutions, speeding up adoption.
• BEN is positioned to receive 35% of applicable gross revenues from Skye Inteligencia LATAM's operations, including Skye Salud, aligning long-term incentives and reinforcing revenue opportunities.
• The Mexican EHR and EMR market is projected for robust double-digit growth, from USD $2.4 billion in 2025 to USD $5.3 billion by 2031 (14% CAGR).
• Skye Salud benefits from world-class clinical leadership from BEN board members Dr. Richard Isaacs and Dr. Ruy Carrasco, ensuring development is guided by physician-executives.
• The platform aims to enhance patient safety, operational efficiency, and personalized care through features like predictive alerts and ambient scribing.

Risks

• Forward-looking statements are subject to inherent uncertainties, risks, and changes in circumstances that may differ materially from anticipated results.
• Risks include those described in Part I, Item 1A of Risk Factors in BEN's Annual Report on Form 10-K for the year ended December 31, 2024, and other SEC filings.
• The success of Skye Salud depends on its ability to integrate seamlessly with existing systems and achieve nationwide adoption in a complex healthcare environment.
• The projected market growth for EHR/EMR systems in Mexico is an independent industry research projection and not a guarantee.

Future Outlook

Skye Salud is targeted for initial pilot programs in Q1 2026 across public hospitals, pharmacy-based clinics, state chronic-disease programs, regional health authorities, and medical education institutions, with a broader rollout to follow. The Mexican EHR and EMR market is projected to grow from USD $2.4 billion in 2025 to USD $5.3 billion by 2031 at approximately 14% CAGR, indicating a robust growth trajectory for the platform's market.

Management Comments

• "Partnering with KNOBLOCH Information Group is transformative for BEN and for healthcare in Mexico. Their dominant position in pharmaceutical data and intelligence, combined with our sovereign AI technology, creates a powerhouse capable of driving real, scalable improvements in clinical care for millions." Tyler Luck, Acting CEO of BEN.
• "Skye Salud unites our extensive healthcare data infrastructure and national reach with cutting-edge augmented intelligence tailored for Mexico. Together, we are laying the foundation for a modern, secure digital ecosystem that can support more consistent and efficient care across the country." Juan Knobloch, M., Director General of KNOBLOCH Information Group.
• "Mexico's opportunity to strengthen quality care and reduce—or potentially eliminate—preventable medical errors coupled with rapid digital-health modernization, reflects broader global trends, with analysts projecting strong double-digit CAGR growth in the country's EHR and EMR market through 2031—reinforcing the strategic importance of building secure, scalable clinical infrastructure through Skye Salud." Dr. Richard Isaacs, BEN board member.

Industry Context

This announcement positions BEN at the forefront of AI-driven healthcare modernization in Mexico, a market facing significant challenges with chronic diseases and fragmented record systems. The venture capitalizes on the projected robust growth of the Mexican EHR and EMR market, which is expected to more than double by 2031. By partnering with KNOBLOCH Information Group, a dominant player in pharmaceutical data, Skye Salud gains a critical advantage in data access and local expertise, differentiating it from potential competitors in a region where data infrastructure has historically been a barrier for effective AI deployment.

Comparison to Industry Standards

• The projected 14% CAGR for Mexico's EHR and EMR market (2025-2031) is a strong double-digit growth, indicating a rapidly expanding market for digital health solutions, comparable to high-growth emerging markets for healthcare technology.
• KNOBLOCH Information Group's audit coverage of 99% of Mexico's private pharmaceutical market and 85% of the overall market at sell-out level demonstrates a level of market dominance and data access that is exceptional, even when compared to global giants in pharmaceutical market intelligence.
• The focus on "sovereign AI" and Spanish-native platforms addresses a critical need for localized, culturally and linguistically appropriate solutions, which is a key differentiator in many non-English speaking markets compared to generic global platforms.
• The involvement of clinical leaders like Dr. Richard Isaacs (former CEO of The Permanente Medical Group, overseeing care for 13M+ patients) brings a level of operational and clinical expertise to Skye Salud that aligns with best practices for large-scale healthcare technology deployments seen in developed markets.

Stakeholder Impact

• Shareholders (BEN): Potential for increased revenue and market expansion into a high-growth sector, enhancing long-term value.
• Patients (Mexico): Enhanced patient safety, improved care continuity, and expanded access to high-quality care through modernized clinical workflows and predictive alerts.
• Clinicians (Mexico): Support with ambient scribing, structured documentation, and population-health insights, augmenting human judgment and improving efficiency.
• Healthcare Institutions (Mexico): Modernization of systems, shift from paper-based workflows to digital, and integration with existing EMRs.
• KNOBLOCH Information Group: Expansion of influence and data utilization into AI-driven clinical intelligence.
• Skye Inteligencia LATAM: Significant role in deploying sovereign AI solutions in Latin America, with two of three board seats in Skye Salud.

Next Steps

• Launch of initial pilot programs for Skye Salud in Q1 2026.
• Broader rollout of the Skye Salud platform to follow pilot programs.
• Continued development of the secure, Spanish-language native augmented-intelligence platform.

Key Dates

Recommendation

The formation of Skye Salud represents a highly strategic and potentially transformative move for Brand Engagement Network, Inc. The partnership with KNOBLOCH Information Group provides unparalleled access to critical healthcare data and market influence in Mexico, a country with a large population and a rapidly growing EHR/EMR market (14% CAGR to $5.3 billion by 2031). BEN's 35% revenue share from this venture, combined with its proprietary sovereign AI technology, positions the company for substantial long-term revenue growth and market leadership in a regulated, high-value sector. The strong clinical leadership and clear phased roadmap further de-risk the execution. This announcement signals a significant expansion of BEN's addressable market and a strong competitive advantage, making it a compelling investment opportunity.

Keywords

Healthcare AI, Mexico Healthcare, Sovereign AI, Digital Health, EMR Market, EHR Market, Brand Engagement Network, KNOBLOCH Information Group, Skye Salud, Skye Inteligencia LATAM, Pharmaceutical Data, Clinical Workflows, Patient Safety, Population Health